Related references
Note: Only part of the references are listed.Shared Risk Factors in Cardiovascular Disease and Cancer
Ryan J. Koene et al.
CIRCULATION (2016)
Screening for Lipid Disorders in Children and Adolescents US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: A meta-analysis
Jing Gong et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
Soy isoflavones and glucose metabolism in menopausal women: A systematic review and meta-analysis of randomized controlled trials
Ke Fang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2016)
Pleiotropic effects of statins in hypercholesterolaemia: a prospective observational study using a lipoproteomic based approach
Sanjay Bhandari et al.
LANCET (2015)
Triglycerides and cardiovascular disease
Borge G. Nordestgaard et al.
LANCET (2014)
HDL and cardiovascular disease
Daniel J. Rader et al.
LANCET (2014)
LDL cholesterol: controversies and future therapeutic directions
Paul M. Ridker
LANCET (2014)
Low dose chromium-polynicotinate or policosanol is effective in hypercholesterolemic children only in combination with glucomannan
Francesco Martino et al.
ATHEROSCLEROSIS (2013)
Nutraceutical and Functional Scenario of Wheat Straw
Imran Pasha et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2013)
New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs
Giuseppe Danilo Norata et al.
EUROPEAN HEART JOURNAL (2013)
Effect of the Growth Stage and Cultivar on Policosanol Profiles of Barley Sprouts and Their Adenosine 5′-Monophosphate-Activated Protein Kinase Activation
Woo Duck Seo et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)
Modified-Policosanol Does Not Reduce Plasma Lipoproteins in Hyperlipidemic Patients When Used Alone or in Combination with Statin Therapy
James M. Backes et al.
LIPIDS (2011)
A systematic review of insomnia and complementary medicine
Jerome Sarris et al.
SLEEP MEDICINE REVIEWS (2011)
Nutritional bioactive components of wheat straw as affected by genotype and environment
Nurhan T. Dunford et al.
BIORESOURCE TECHNOLOGY (2010)
Policosanols as Nutraceuticals: Fact or Fiction
Christopher P. F. Marinangeli et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2010)
Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: A double blind, controlled study
F. Francini-Pesenti et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2008)
Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia
F. Francini-Pesenti et al.
PHYTOTHERAPY RESEARCH (2008)
Comparison of composition and absorption of sugarcane policosanols
Christopher P. F. Marinangeli et al.
BRITISH JOURNAL OF NUTRITION (2007)
Comparative lipid-lowering effects of policosanol and atorvastatin: A randomized, parallel, double-blind, placebo-controlled trial
Luigi X. Cubeddu et al.
AMERICAN HEART JOURNAL (2006)
Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase
Dev K. Singh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia - A randomized controlled trial
HK Berthold et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia
G Castano et al.
DRUGS & AGING (2003)
Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients
ML Arruzazabala et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2002)
A randomized, double-blind, placebo-controlled study of the efficacy and tolerability of policosanol in adolescents with type II hypercholesterolemia
G Castaño et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2002)
Policosanol: Clinical pharmacology and therapeutic significance of a new lipid-lowering agent
I Gouni-Berthold et al.
AMERICAN HEART JOURNAL (2002)
Comparison of two regimens of policosanol administered at 20 mg/d in patients with type II hypercholesterolemia:: A randomized, double-blind, placebo-controlled study
G Castaño et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2001)
Comparison of the efficacy, safety and tolerability of policosanol versus fluvastatin in elderly hypercholesterolaemic women
JC Fernandez et al.
CLINICAL DRUG INVESTIGATION (2001)
Effects of bezafibrate plus policosanol or placebo in patients with combined dyslipidemia:: A pilot study
S Marcello et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2000)
Efficacy and tolerability of policosanol compared with lovastatin in patients with type II hypercholesterolemia and concomitant coronary risk factors
G Castaño et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2000)
Effects of policosanol on the susceptibility of low-density lipoprotein isolated from hypercholesterolemic patients at high coronary risk to in vitro copper-mediated lipid peroxidation: A randomized, double-blind pilot study
R Menendez et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2000)
Share Paper
